| The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a … J Epstein, L Egevad, M Amin, B Delahunt, J Srigley, P Humphrey, ... The American Journal of Surgical Pathology 40 (2), 244-252, 2016 | 3309 | 2016 |
| Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a … SIM Singer G1, Stöhr R, Cope L, Dehari R, Hartmann A, Cao DF, Wang TL, Kurman RJ The American Journal of Surgical Pathology 29 (2), 218-24, 2005 | 538 | 2005 |
| Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma S Begum, D Cao, M Gillison, M Zahurak, WH Westra Clinical Cancer Research 11 (16), 5694-5699, 2005 | 399 | 2005 |
| Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs) YM Hashim, KM Trinkaus, DC Linehan, SS Strasberg, RC Fields, D Cao, ... Annals of surgery 259 (2), 197-203, 2014 | 271 | 2014 |
| Prospective study of [18F] fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma AS Kibel, F Dehdashti, MD Katz, AP Klim, RL Grubb, PA Humphrey, ... Journal of Clinical Oncology 27 (26), 4314, 2009 | 263 | 2009 |
| SALL4 is a novel diagnostic marker for testicular germ cell tumors D Cao, J Li, CC Guo, RW Allan, PA Humphrey The American journal of surgical pathology 33 (7), 1065-1077, 2009 | 258 | 2009 |
| SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma D Cao, S Guo, RW Allan, KH Molberg, Y Peng The American journal of surgical pathology 33 (6), 894-904, 2009 | 208 | 2009 |
| Alternative lengthening of telomeres and loss of DAXX/ATRX expression predicts metastatic disease and poor survival in patients with pancreatic neuroendocrine tumors AD Singhi, TC Liu, JL Roncaioli, D Cao, HJ Zeh, AH Zureikat, A Tsung, ... Clinical Cancer Research 23 (2), 600-609, 2017 | 204 | 2017 |
| SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors D Cao, PA Humphrey, RW Allan Cancer 115 (12), 2640-2651, 2009 | 174 | 2009 |
| Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions D Cao, C Lin, SH Woo, R Vang, TN Tsangaris, P Argani The American journal of surgical pathology 29 (12), 1625-1632, 2005 | 161 | 2005 |
| Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors A Liu, L Cheng, J Du, Y Peng, RW Allan, L Wei, J Li, D Cao The American journal of surgical pathology 34 (5), 697-706, 2010 | 135 | 2010 |
| Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor–expressing triple-negative breast carcinoma LM Sutton, D Cao, V Sarode, KH Molberg, K Torgbe, B Haley, Y Peng American journal of clinical pathology 138 (4), 511-516, 2012 | 121 | 2012 |
| Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker CJ O'Conor, T Chen, I González, D Cao, Y Peng Biomarkers in medicine 12 (7), 813-820, 2018 | 119 | 2018 |
| Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein … F Wang, A Liu, Y Peng, D Rakheja, L Wei, D Xue, RW Allan, KH Molberg, ... The American journal of surgical pathology 33 (10), 1529-1539, 2009 | 117 | 2009 |
| Genomic classifications of renal cell carcinoma: A critical step towards the future application of personalized kidney cancer care with pan‐omics precision JJ Hsieh, V Le, D Cao, EH Cheng, CJ Creighton The Journal of pathology 244 (5), 525-537, 2018 | 115 | 2018 |
| Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from … D Cao, H Ji, BM Ronnett International journal of gynecological pathology 24 (1), 67-72, 2005 | 115 | 2005 |
| Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways D Cao, A Maitra, JA Saavedra, DS Klimstra, NV Adsay, RH Hruban Modern pathology 18 (6), 752-761, 2005 | 113 | 2005 |
| Neoadjuvant therapy of pancreatic cancer: the emerging paradigm? KH Lim, E Chung, A Khan, D Cao, D Linehan, E Ben-Josef, ... The oncologist 17 (2), 192-200, 2012 | 109 | 2012 |
| Class III β‐tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia KM Lee, D Cao, A Itami, PM Pour, RH Hruban, A Maitra, MM Ouellette Histopathology 51 (4), 539-546, 2007 | 107 | 2007 |
| Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression SR Hustinx, D Cao, A Maitra, N Sato, S Martin, D Sudhir, ... Cancer biology & therapy 3 (12), 1254-1261, 2004 | 104 | 2004 |
